Abstract
The mature sporadic T-cell malignancy, T-cell prolymphocytic leukemia (T-PLL) is remarkable for frequently harbouring somatic mutations of the Ataxia Telangiectasia (A-T) gene, ATM. Because some data suggest ATM is frequently rearranged in T-PLL, it was decided to investigate such rearrangements in detail by cloning breakpoints. Among 17 T-PLL tumour samples, three rearrangements were detected by Southern blotting. Two cases harboured a unique type of intragenic duplication in which breakpoints arose at the consensus sequence RGYW/WRCY. The third case harboured a large deletion terminating within the ATM gene. Also, 13 T-cell acute lymphoblastic leukemia (T-ALL) samples were examined and one sample harboured a deletion– insertion with the RGYW motif at the breakpoint in ATM. This is the first known deleterious mutation detected in ATM in T-ALL. Interestingly, the RGYW motif is the signal for a cell-cycle regulated DNA double strand break (DSB) that initiates somatic hypermutation of immunoglobulin and, probably, T-cell receptor genes. The structures of the ATM duplications suggest they may arise from an error in somatic hypermutation. We suggest that aberrant components of somatic hypermutation may contribute to the defective DSB repair characteristic of cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- A-T:
-
Ataxia Telangiectasia
- ATM :
-
Ataxia Telangiectasia Mutated gene
- T-PLL:
-
T-cell prolymphocytic leukemia
- T-ALL:
-
T-cell acute lymphoblastic leukemia
- TCR:
-
T-cell receptor
References
Hacia JG, Sun B, Hunt N, Edgemon K, Mosbrook D, Robbins C, Fodor SP, Tagle DA, Collins FS . 1998 Genome Res. 8: 1245–1258
Haidar MA, Kantarjian H, Manshouri T, Chang CY, O'Brien S, Freireich E, Keating M, Albitar M . 2000 Cancer 88: 1057–1062
Hecht F, Hecht BK . 1990 Cancer Genet. Cytogenet. 46: 9–19
Izatt L, Greenman J, Hodgson S, Ellis D, Watts S, Scott G, Jacobs C, Liebmann R, Zvelebil MJ, Mathew C, Solomon E . 1999 Genes Chromos. Cancer 26: 286–294
Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, Kuppers R . 1998 Immunol. Rev. 162: 261–280
Luo L, Lu FM, Hart S, Foroni L, Rabbani H, Hammarström L, Yuille MR, Catovsky D, Webster AD, Vorechovsky I . 1998 Cancer Res. 58: 2293–2297
Meyn MS . 1999 Clin. Genet. 55: 289–304
Papavasiliou F-N, Schatz D-G . 2000 Nature 408: 216–221
Pasqualucci L, Neri A, Baldini L, Dalla-Favera R, Migliazza A . 2000 Cancer Res. 60: 5644–5648
Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K, Dalla-Favera R . 1998 Proc. Natl. Acad. Sci. USA 95: 11816–11821
Ravid Z, Goldblum N, Zaizov R, Schlesinger M, Kertes T, Minowada J, Verbi W, Greaves M . 1980 Int. J. Cancer 25: 705–709
Shen HM, Peters A, Baron B, Zhu X, Storb U . 1998 Science 280: 1750–1752
Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM . 1998 Am. J. Hum. Genet. 62: 334–345
Stankovic T, Taylor AMR, Vorechovsky I, Yuille MAR . 2001 Blood 97: 1517–1518
Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Dohner H . 1997 Nature Med. 3: 1155–1159
Stoppa-Lyonnet D, Lauge A, Sigaux F, Stern M-H . 2000 Blood 96: 374–376
Takeuchi S, Koike M, Park S, Seriu T, Bartram CR, Taub HE, Williamson IK, Grewal J, Taguchi H, Koeffler HP . 1998 Br. J. Haematol. 103: 536–538
Taylor AMR, Metcalfe JA, Thick J, Mak YF . 1996 Blood 87: 423–428
Vanasse GJ, Concannon P, Willerford DM . 1999 Blood 94: 3997–4010
Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster ADB, Yuille MAR . 1997 Nature Genet. 17: 96–99
Yuille MAR, Coignet LJA, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovsky I, Dyer MJS, Catovsky D . 1998 Oncogene 16: 789–796
Zheng B, Xue W, Kelsoe G . 1994 Nature 372: 556–559
Acknowledgements
We thank Ray Powles (Royal Marsden NHS Trust Hospital) for samples. PS Bradshaw is a Gordon Piller Scholar of the Leukemia Research Fund. We acknowledge support from the Kay Kendall Leukemia Trust.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bradshaw, P., Condie, A., Matutes, E. et al. Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motif. Oncogene 21, 483–487 (2002). https://doi.org/10.1038/sj.onc.1205105
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205105